Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?

Nicolas Picard

doi:10.1038/clpt.2010.16

Journal Articles Clinical Pharmacology and Therapeutics Year : 2010

Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?

(1, 2)

1
2

Nicolas Picard

Function : Correspondent author
PersonId : 863136

Connectez-vous pour contacter l'auteur

Pharmacologie des Immunosuppresseurs et de la Transplantation

Service de Pharmacologie, toxicologie et pharmacovigilance [CHU Limoges]

Abstract

n.a

Keywords

TACROLIMUS

Domains

Life Sciences [q-bio] Pharmaceutical sciences

Fichier principal

inserm-00446918_edited.pdf (87.94 Ko)

Letter_to_the_Editor_interaction_MMF_TAC_.pdf (76.03 Ko)

Origin : Files produced by the author(s)

Pierre Marquet : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00446918

Submitted on : Friday, October 15, 2010-4:01:29 PM

Last modification on : Sunday, June 26, 2022-1:22:35 PM

Long-term archiving on: Sunday, January 16, 2011-2:27:06 AM

Dates and versions

inserm-00446918 , version 1 (15-10-2010)

Identifiers

HAL Id : inserm-00446918 , version 1
DOI : 10.1038/clpt.2010.16
PUBMED : 20393455

Cite

Nicolas Picard. Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?. Clinical Pharmacology and Therapeutics, 2010, 87 (6), pp.650-1. ⟨10.1038/clpt.2010.16⟩. ⟨inserm-00446918⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNILIM CNRS UMR-S850 GEIST IPPRITT OMEGAHEALTH

63 View

233 Download

Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?

Abstract

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share